Herbert Loong: NTRK gene fusion testing in the management of NSCLC
Herbert Loong, Chair-Elect of the International Affairs Committee of ASCO, shared a post on X about a recent paper by him and colleagues published in Cancer Treatment Reviews:
“Our recent review paper on NTRK gene fusion testing in the management of NSCLC. A truly international effort to consolidate best practice recommendations for testing and treatment of NTRK positive disease.”
“NTRK gene fusion testing and management in lung cancer”
Authors: Matteo Repetto, Marina Chiara Garassino, Herbert Loong, Fernando Lopez-Rios, Tony Mok, Solange Peters, David Planchard, Sanjay Popat, Erin Rudzinski, Alexander Drilon, Caicun Zhou.
More posts featuring Herbert Loong.
Dr. Herbert H. F. Loong is the Chair-Elect of the International Affairs Committee, a Scientific Track Member (2022-2024), and the Track Leader for Sarcoma (2023) at the American Society of Clinical Oncology (ASCO). Additionally, he has been promoted to Steering Committee Member at the Lung Cancer Policy Network.
Dr. Loong is also the Chairperson of the Asia Pacific Coalition against Lung Cancer, a Board Member of the Connective Tissue Oncology Society, and a Committee Member of the International Association for the Study of Lung Cancer. He is an Associate Professor in the Department of Clinical Oncology at The Chinese University of Hong Kong (CUHK).
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023